Adam G I, Miller S J, Ullerås E, Franklin G C
Department of Animal Development and Genetics, University of Uppsala, Sweden.
Gene. 1996 Oct 31;178(1-2):25-9. doi: 10.1016/0378-1119(96)00318-6.
The human platelet-derived growth factor-B (PDGF-B) gene has been shown to display a wide range of levels of mRNA transcription in a variety of cell types. Functional analyses of PDGF-B gene expression have begun to reveal intricate, cell-type-specific regulatory mechanisms involving multiple control elements. We have previously isolated and characterised several elements involved in the control of human PDGF-B gene expression in the JEG-3 choriocarcinoma cell line and in the breast cancer-derived cell line, ZR-75. Assessment of the positive or negative regulatory contributions of these elements was carried out using transient transfection assays. Such studies routinely require the inclusion of a reference plasmid in order to determine transfection efficiency. Here we show that competition for regulatory factors occurs in transfected cells between viral enhancers and elements regulating PDGF-B gene transcription. A frequently used reference plasmid which utilises the SV40 promoter and enhancer region to drive expression of a beta-galactosidase reporter gene was found to severely repress the activity of a co-transfected reporter construct containing the PDGF-B promoter and its intronic enhancer in JEG-3 cells. This competition was localised to the enhancer region of the SV40 regulatory sequences and surprisingly, the effect was reversed in ZR-75 cells; where increasing the amount of reference plasmid strongly stimulated the activity of the PDGF-B construct. These results imply that the same intronic region which functions equally well as an enhancer in two distinct cell-types, may operate in response to different transcription factor complements. Furthermore, this data demonstrates that the choice of reference plasmid and its quantitative use can be a crucial factor when examining putative regulatory elements by transient transfection methods.
人血小板衍生生长因子-B(PDGF-B)基因已被证明在多种细胞类型中表现出广泛的mRNA转录水平。对PDGF-B基因表达的功能分析已开始揭示涉及多个控制元件的复杂的、细胞类型特异性的调控机制。我们之前已经分离并鉴定了在JEG-3绒毛膜癌细胞系和乳腺癌衍生细胞系ZR-75中参与人PDGF-B基因表达调控的几个元件。使用瞬时转染试验评估了这些元件的正调控或负调控作用。此类研究通常需要包含一个参考质粒以确定转染效率。在此我们表明,在转染细胞中,病毒增强子与调控PDGF-B基因转录的元件之间存在对调控因子的竞争。发现一种常用的利用SV40启动子和增强子区域驱动β-半乳糖苷酶报告基因表达的参考质粒,在JEG-3细胞中会严重抑制共转染的包含PDGF-B启动子及其内含子增强子的报告构建体的活性。这种竞争定位于SV40调控序列的增强子区域,令人惊讶的是,在ZR-75细胞中这种效应是相反的;在ZR-75细胞中增加参考质粒的量会强烈刺激PDGF-B构建体的活性。这些结果表明,在两种不同细胞类型中同样作为增强子发挥良好作用的同一内含子区域,可能会因不同的转录因子组合而发挥作用。此外,这些数据表明,在通过瞬时转染方法检测假定的调控元件时,参考质粒的选择及其定量使用可能是一个关键因素。